Becton Dickinson, Gen-Probe, and Cepheid last week updated attendees of an investor conference on their development timelines for upcoming nucleic acid testing platforms and assays.

Speaking at the JP Morgan Healthcare Conference in San Francisco, the tool vendors emphasized their plans to launch automated testing platforms intended to reduce the time and complexity of nucleic acid-based molecular diagnostic testing.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.